Ryan Deschner Raymond James News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ryan deschner raymond james. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ryan Deschner Raymond James Today - Breaking & Trending Today

Gilead Sciences (GILD) Q1 2023 Earnings Call Transcript

GILD earnings call for the period ending March 31, 2023. ....

United States , Tim Anderson , America Merrill Lynch , Olivia Brayer Cantor Fitzgerald , Merdad Parsey , Salveen Richter , Randy Dickinson , Brian Skorney , Raymond James , Tyler Van Buren Cowen , Charlie Moore , Chris Schott , Geoff Meacham , Ryan Deschner , Olivia Brayer , Michael Yee , Ryan Deschner Raymond James , Merrell Bio , Tyler Van Buren , Terence Flynn , Johanna Mercier , Hartaj Singh Oppenheimer , Chris Schott Jpmorgan , Terence Flynn Morgan Stanley , Mohit Bansal , Brian Abrahams ,

ChemoCentryx, inc (CCXI) Q2 2021 Earnings Call Transcript

ChemoCentryx, inc (CCXI) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United States , Vifor Pharma , Thomas Schall , Raymond James , Ted Tenthoff Piper Sandler , Michelle Gilson , Hidradenitis Suppurativa , Steve Seedhouse , Dburns Mcclellan , Susan Kanaya , Yanan Zhu , Red White , Thomasj Schall , Michelle Gilson Canaccord Genuity , Susanm Kanaya , Ryan Deschner , Piper Sandler , Ryan Deschner Raymond James , Ted Tenthoff , Lee Roth , Joseph Schwartz , American Association Of Dermatology , Exchange Commission , American Association For Cancer Research , European Medicines Agency , Devices Agency ,

Intercept Pharmaceuticals Inc (ICPT) Q1 2021 Earnings Call Transcript

Operator
Welcome to the Q1 2021 Intercept Pharmaceuticals Earnings Call. My name is Anette, and I ll be your operator for today s call. [Operator Instructions]
I will now turn the call over to Lisa DeFrancesco. Lisa, you may begin.
Lisa DeFrancesco
Senior Vice President of Investor Relations and Corporate Affairs
Thank you. Good morning, and thank you for joining us on today s call. This morning, we issued a press release announcing our first quarter 2021 results and financial position, which is available on our website at www.interceptpharma.com. Before we begin our discussion, I d like to note that during our call, we will be making forward-looking statements, including statements regarding our approved product and clinical development program; certain regulatory matters; and our strategy, prospects, financial guidance and future commercial and financial performance. Listeners are cautioned not to place undue reliance on these forward-looking statements, w ....

United States , Gail Cawkwell , Jerome Durso , Raymond James , Chris Weyer , Linda Richardson , Steve Seedhouse , Jay Olson Oppenheimer , Lisa Defrancesco , Michael Yee , Jerry Durso , Brian Abrahams , Jay Olson , Rocco Venezia , David Cithu , Mark Pruzanski , Ryan Deschner , Piper Sandler , Jesse Piper Sandler , Navin Jacob , Ryan Deschner Raymond James , Thomas Smith , Emily Cantor Fitzgerald , Cantor Fitzgerald , Intercept Pharmaceuticals Inc , Intercept Pharmaceuticals Earnings Call ,

Viking Therapeutics (VKTX) Q1 2021 Earnings Call Transcript

Operator
Welcome to the Viking Therapeutics 2021 first-quarter financial results conference call. [Operator instructions] As a reminder, this conference call is being recorded today, April 28th, 2021. I would now like to turn the conference over to Viking s manager of investor relations, Stephanie Diaz. Please go ahead, Stephanie.
Stephanie Diaz
Manager of Investor Relations
Hello, and thank you all for participating in today s call. Joining me today is Brian Lian, Viking s president and CEO; and Greg Zante, Viking s CFO. Before we begin, I d like to caution that comments made during this conference call, today, April 28th, 2021, will contain forward-looking statements under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about Viking s expectations regarding its development activities, timelines, and milestones. ....

Andy Hsieh , Michael Morabito Chardan , Raymond James , Mayank Mamtani , Derek Archila , Steve Seedhouse , Andy Hsieh William Blair , Matthew Luchini , Stephanie Diaz , Jay Olson , Sahil Kazmi , Michael Morabito , Ryan Deschner , Greg Zante , Ryan Deschner Raymond James , Scott Henry , Sahil Kazmib Riley , William Blair , Exchange Commission , Jay Olson Oppenheimer Co , International Liver Congress , Viking Therapeutics , Viking Therapeutic , Brian Lian , Securities Litigation Reform Act , Chief Executive ,